Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · January 14, 2023

Association of Respiratory and Cardiometabolic Comorbidities With Survival Outcomes in Patients With Stages I to III NSCLC

Journal of Thoracic Oncology

 

Additional Info

Journal of Thoracic Oncology
Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium
J Thorac Oncol 2022 Nov 15;[EPub Ahead of Print], M García-Pardo, A Chang, S Schmid, M Dong, MC Brown, D Christiani, HA Tindel, P Brennan, C Chen, J Zhang, BM Ryan, D Zaridze, MB Schabath, LF Leal, RM Reis, A Tardon, G Fernández-Tardon, SS Shete, A Andrew, H Brenner, W Xu, RJ Hung, G Liu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading